Justin Walsh
Stock Analyst at JonesTrading
(4.75)
# 641
Out of 4,574 analysts
381
Total ratings
38.9%
Success rate
21.1%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI AtaiBeckley | Downgraded: Hold | n/a | $7.18 | - | 8 | Jul 16, 2026 | |
| ANRO Alto Neuroscience | Reiterated: Buy | $44 | $26.78 | +64.30% | 19 | Jun 26, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $61 → $74 | $43.17 | +71.42% | 6 | Jun 23, 2026 | |
| BLRX BioLineRx | Reiterated: Buy | $12 | $2.82 | +325.53% | 10 | Jun 2, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $441 | $325.30 | +35.57% | 11 | Jun 2, 2026 | |
| VNRX VolitionRx | Reiterated: Buy | $60 → $24 | $1.00 | +2,300.00% | 5 | May 18, 2026 | |
| SER Serina Therapeutics | Reiterated: Buy | $11 | $2.07 | +431.40% | 8 | May 18, 2026 | |
| CLNN Clene | Reiterated: Buy | $30 | $5.39 | +456.59% | 14 | May 15, 2026 | |
| RNXT RenovoRx | Reiterated: Buy | $8 | $0.8653 | +824.53% | 4 | May 15, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $18 | $2.91 | +518.56% | 34 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.90 | +321.05% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.22 | +160.66% | 14 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $6.10 | +227.87% | 23 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $104.82 | - | 30 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $40.68 | +22.91% | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.86 | +946.51% | 32 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $3.55 | +745.07% | 7 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $5.16 | +675.19% | 11 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $19.26 | - | 27 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $109.87 | n/a | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.83 | n/a | 16 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.40 | $0.02 | n/a | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $2.95 | n/a | 6 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $4 | $1.08 | n/a | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.89 | n/a | 12 | Jun 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $38.45 | n/a | 2 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $0.3243 | n/a | 15 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.07 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $0.36 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $42.59 | n/a | 2 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.000001 | n/a | 2 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.03 | n/a | 2 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.40 | n/a | 3 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $20.81 | n/a | 5 | Nov 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $0.216 | n/a | 1 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $1.42 | n/a | 1 | Feb 17, 2021 |
AtaiBeckley
Jul 16, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.18
Upside: -
Alto Neuroscience
Jun 26, 2026
Reiterated: Buy
Price Target: $44
Current: $26.78
Upside: +64.30%
Definium Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $61 → $74
Current: $43.17
Upside: +71.42%
BioLineRx
Jun 2, 2026
Reiterated: Buy
Price Target: $12
Current: $2.82
Upside: +325.53%
Praxis Precision Medicines
Jun 2, 2026
Reiterated: Buy
Price Target: $441
Current: $325.30
Upside: +35.57%
VolitionRx
May 18, 2026
Reiterated: Buy
Price Target: $60 → $24
Current: $1.00
Upside: +2,300.00%
Serina Therapeutics
May 18, 2026
Reiterated: Buy
Price Target: $11
Current: $2.07
Upside: +431.40%
Clene
May 15, 2026
Reiterated: Buy
Price Target: $30
Current: $5.39
Upside: +456.59%
RenovoRx
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $0.8653
Upside: +824.53%
Perspective Therapeutics
May 14, 2026
Reiterated: Buy
Price Target: $18
Current: $2.91
Upside: +518.56%
May 13, 2026
Reiterated: Buy
Price Target: $8
Current: $1.90
Upside: +321.05%
May 13, 2026
Reiterated: Buy
Price Target: $11
Current: $4.22
Upside: +160.66%
May 12, 2026
Reiterated: Buy
Price Target: $20
Current: $6.10
Upside: +227.87%
May 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $104.82
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $50
Current: $40.68
Upside: +22.91%
Apr 2, 2026
Reiterated: Buy
Price Target: $9
Current: $0.86
Upside: +946.51%
Mar 25, 2026
Reiterated: Buy
Price Target: $30
Current: $3.55
Upside: +745.07%
Mar 11, 2026
Reiterated: Buy
Price Target: $40
Current: $5.16
Upside: +675.19%
Jan 5, 2026
Rated: Hold
Price Target: n/a
Current: $19.26
Upside: -
May 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $109.87
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $3.83
Upside: n/a
Oct 30, 2024
Reiterated: Buy
Price Target: $0.40
Current: $0.02
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $20
Current: $2.95
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: $8 → $4
Current: $1.08
Upside: n/a
Jun 6, 2022
Reiterated: Buy
Price Target: $10
Current: $4.89
Upside: n/a
May 19, 2022
Maintained: Buy
Price Target: $16 → $20
Current: $38.45
Upside: n/a
May 19, 2022
Reiterated: Buy
Price Target: $18
Current: $0.3243
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $10
Current: $2.07
Upside: n/a
May 4, 2022
Maintained: Buy
Price Target: $7 → $6
Current: $0.36
Upside: n/a
Apr 7, 2022
Maintained: Buy
Price Target: $10
Current: $42.59
Upside: n/a
Jan 11, 2022
Upgraded: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $6.03
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $5.40
Upside: n/a
Nov 17, 2021
Reiterated: Buy
Price Target: $30
Current: $20.81
Upside: n/a
Sep 2, 2021
Initiated Coverage: Buy
Price Target: $40
Current: $0.216
Upside: n/a
Feb 17, 2021
Initiated Coverage: Buy
Price Target: $4
Current: $1.42
Upside: n/a